Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Raimundo Fernandes

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
European Journal of Gastroenterology & Hepatology|June 18, 2025
Outcomes of acute severe ulcerative colitis at initial presentationDiogo Couto Sousa, Samuel Raimundo Fernandes, Sofia Saraiva, et al.
Journal of Clinical Laboratory Analysis|May 18, 2016
Ascitic Calprotectin is a Novel and Accurate Marker for Spontaneous Bacterial PeritonitisSamuel Raimundo Fernandes, Patrícia Santos, Narcisa Fatela, et al.
European Journal of Gastroenterology & Hepatology|March 11, 2026
Fecal calprotectin-guided treatment escalation strategy enhances disease clearance in ulcerative colitisInês Coelho Rodrigues, Samuel Raimundo Fernandes, Sofia Saraiva, et al.
Revista Espanola De Enfermedades Digestivas|January 21, 2016
Primary liposarcoma of the sigmoid presenting as colonic intussusception - A case reportSamuel Raimundo Fernandes, Ana Rita Gonçalves, João Lopes, et al.
Inflammatory Bowel Diseases|November 20, 2023
Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn's Disease: A Propensity Score-Matched AnalysisSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
Inflammatory Bowel Diseases|June 28, 2019
Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel DiseaseSamuel Raimundo Fernandes, Sónia Bernardo, Carolina Simões, et al.
United European Gastroenterology Journal|December 14, 2023
Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's diseaseSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
United European Gastroenterology Journal|May 16, 2024
The degree of bowel remission predicts phenotype progression in Crohn's diseaseSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
Inflammatory Bowel Diseases|April 4, 2026
Transmural improvement may be an acceptable target in patients with Crohns diseaseSamuel Raimundo Fernandes, Sérgio Bronze, Inês Coelho Rodrigues, et al.
European Journal of Gastroenterology & Hepatology|March 18, 2021
Proactive therapeutic drug monitoring is more effective than conventional management in inducing fecal calprotectin remission in inflammatory bowel diseaseSamuel Raimundo Fernandes, Juliana Serrazina, Inês Coelho Rodrigues, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Gastroenterology & Hepatology|June 18, 2025
Outcomes of acute severe ulcerative colitis at initial presentationDiogo Couto Sousa, Samuel Raimundo Fernandes, Sofia Saraiva, et al.
Journal of Clinical Laboratory Analysis|May 18, 2016
Ascitic Calprotectin is a Novel and Accurate Marker for Spontaneous Bacterial PeritonitisSamuel Raimundo Fernandes, Patrícia Santos, Narcisa Fatela, et al.
European Journal of Gastroenterology & Hepatology|March 11, 2026
Fecal calprotectin-guided treatment escalation strategy enhances disease clearance in ulcerative colitisInês Coelho Rodrigues, Samuel Raimundo Fernandes, Sofia Saraiva, et al.
Revista Espanola De Enfermedades Digestivas|January 21, 2016
Primary liposarcoma of the sigmoid presenting as colonic intussusception - A case reportSamuel Raimundo Fernandes, Ana Rita Gonçalves, João Lopes, et al.
Inflammatory Bowel Diseases|November 20, 2023
Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn's Disease: A Propensity Score-Matched AnalysisSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
Inflammatory Bowel Diseases|June 28, 2019
Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel DiseaseSamuel Raimundo Fernandes, Sónia Bernardo, Carolina Simões, et al.
United European Gastroenterology Journal|December 14, 2023
Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's diseaseSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
United European Gastroenterology Journal|May 16, 2024
The degree of bowel remission predicts phenotype progression in Crohn's diseaseSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
Inflammatory Bowel Diseases|April 4, 2026
Transmural improvement may be an acceptable target in patients with Crohns diseaseSamuel Raimundo Fernandes, Sérgio Bronze, Inês Coelho Rodrigues, et al.
European Journal of Gastroenterology & Hepatology|March 18, 2021
Proactive therapeutic drug monitoring is more effective than conventional management in inducing fecal calprotectin remission in inflammatory bowel diseaseSamuel Raimundo Fernandes, Juliana Serrazina, Inês Coelho Rodrigues, et al.
Pageof 3